FDA Requests Comment On International Classification Of Marijuana, To Be Reviewed By WHO

Forbes: Feds Want Input On Marijuana Reclassification
“…[T]he United Nations World Health Organization is set to launch a review of the current international classification of marijuana, THC, cannabidiol, and other related compounds and preparations, and it wants input from member nations. In turn, the U.S. Food and Drug Administration is asking ‘interested persons’ to submit comments that can inform the country’s position on the issue before it weighs in with the U.N…” (Angell, 4/6).

Washington Times: FDA seeking input on medical marijuana ahead of World Health Organization meeting
“…The FDA ‘is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of five drug substances,’ including cannabis and its compounds, according to a notice slated to be published Monday in the Federal Register. … Countries that have passed federal laws legalizing medical marijuana include Australia, Canada, Germany, Mexico, and Peru, among others” (Blake, 4/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.